What is the appropriate management for hyperemesis gravidarum at 19 weeks gestation?

Management of Hyperemesis Gravidarum at 19 Weeks Gestation

Continue aggressive antiemetic therapy with combination medications if needed, ensure adequate hydration with IV fluids containing potassium chloride if oral intake is insufficient, provide mandatory thiamine supplementation, initiate thromboprophylaxis, and arrange serial fetal growth scans for the remainder of pregnancy. 1

Immediate Assessment and Monitoring

At 19 weeks, you must assess severity using validated tools (PUQE or HELP scores) rather than relying on ketonuria, which does not indicate dehydration severity 1. Check daily urea and electrolytes if IV fluids are required 1. This gestational age is critical because HG persisting into the late second trimester significantly increases risks of preterm birth and low birth weight 1.

Pharmacological Management Algorithm

First-Line Antiemetics (if not already tried)

• Antihistamines (H1 blockers), phenothiazines, or doxylamine/pyridoxine (Xonvea®) have Grade A safety and efficacy data 1
• These should be prescribed without hesitation

Second-Line Antiemetics (escalate immediately if first-line fails)

• Ondansetron: Safe and effective despite minimal absolute risk increase in orofacial clefting (first trimester concern only—you're past this at 19 weeks). Do not discourage its use 1
• Metoclopramide: Safe and effective, use alone or in combination. Administer IV doses slowly over ≥3 minutes to minimize extrapyramidal effects 1

Combination Therapy

Use multiple antiemetics simultaneously if single agents fail 1. This is not optional—women who don't respond to monotherapy require combination regimens immediately.

Alternative Pharmacotherapeutics for Refractory Cases

If standard antiemetics fail, consider mirtazapine, olanzapine, corticosteroids, or gabapentin 2. However, corticosteroid data is limited (maximum ~3,500 first-trimester exposures) 1.

Hydration and Electrolyte Management

• Normal saline (0.9% NaCl) with potassium chloride added to each bag, guided by daily electrolyte monitoring 1
• Monitor and correct hyponatremia and hypokalemia aggressively 1

Mandatory Thiamine Supplementation

Give thiamine 100 mg three times daily orally OR IV vitamin B complex (Pabrinex®) to ALL women with vomiting or severely reduced dietary intake, especially before any dextrose or parenteral nutrition 1. This prevents Wernicke encephalopathy, which causes chronic cognitive disorders in 65%, pregnancy loss in 50%, and maternal death in 5% of cases 1. This is non-negotiable.

Thromboprophylaxis

Initiate low-molecular-weight heparin immediately 1. Women with HG have an adjusted odds ratio of 4.4 for deep vein thrombosis 1. Continue until symptoms resolve and oral intake is adequate. Use graduated compression stockings if LMWH is contraindicated 1.

Additional Interventions

• Proton pump inhibitors or H2 blockers for gastroesophageal reflux, which commonly accompanies HG 1
• Avoid or modify iron supplementation if it exacerbates symptoms—two-thirds of women report improvement when iron is discontinued 1
• Consider enteral or parenteral nutrition if prolonged inability to tolerate oral intake with ongoing weight loss 2

Fetal Surveillance

Arrange serial growth scans for the remainder of pregnancy 1. Women with severe NVP/HG continuing into late second or third trimester, particularly those with low pregnancy weight gain (<7 kg total), face increased risk of preterm birth and low birth weight 1.

Discharge and Ongoing Care

Only discharge when:

1. Appropriate antiemetic therapy is tolerated
2. Adequate oral nutrition and hydration is tolerated
3. Concurrent conditions are managed 1

Ensure continued antiemetic therapy after discharge—nearly one-third of women require readmission 1. Establish clear access to ambulatory day care for rehydration and antiemetic review if symptoms recur 1.

Critical Pitfalls to Avoid

• Do not use ketonuria to guide treatment decisions—it does not reflect hydration status 1
• Do not withhold antiemetics due to teratogenicity concerns—the risks of poorly managed HG far outweigh minimal medication risks, especially at 19 weeks 1
• Do not give IV dextrose or parenteral nutrition without thiamine first—this precipitates Wernicke encephalopathy 1
• Do not delay combination antiemetic therapy—single agents frequently fail in HG 1

Quality of Life Considerations

HG at this gestational age severely impairs daily functioning, relationships, work capacity, and mental health 1. Aggressive symptom control directly impacts maternal morbidity and quality of life, which must be prioritized alongside fetal outcomes.